Month: March 2011

Manel Esteller bestowed with the European Association for Cancer Research (EACR) Award Lecture

Manel Esteller has authored more than two-hundred seventy original articles and has placed epigenetics in the forefront of cancer biology. He is the Director of the Cancer Epigenetics and Biology Program (PEBC) of the Bellvitge Biomedical Research Institute (IDIBELL), an ICREA Research Professor and Genetics Professor in the School of Medicine of the University of …

Manel Esteller bestowed with the European Association for Cancer Research (EACR) Award Lecture Read More »

IDIBELL researcher Oriol Casanovas publishes a commentary about anti-angiogenic therapies in Journal of Clinical Investigation

Casanovas stresses that these findings may be very clinically relevant, and that therapies that combine inhibition of more than one angiogenic pathway might be useful in circumventing resistance. In late 2010, the agency Thomson Reuters, in its report Science Watch, stressed a study coordinated by Oriol Casanovas about the negative consequences of antiangiogenic therapies as …

IDIBELL researcher Oriol Casanovas publishes a commentary about anti-angiogenic therapies in Journal of Clinical Investigation Read More »

Isabel Fabregat, elected new president of the Spanish Society of Cell Biology

SEBC is a professional association, opens to cell Biology professionals, that was founded in 1984 with the objectives of promoting the development of this specialty, to facilitate scientific exchange with the international scientific community by organizing courses and conferences and promoting the Spanish participation at international meetings.

IDIBELL launches an experimental cardiology program focusing on research of personalized treatments

This is the first laboratory of its kind in Catalonia IDIBELL launches an experimental cardiology program designed to develop custom clinical applications.  The program specializes in the functional study of platelets and evaluation of the response to antithrombotic and lipid-lowering drugs (decrease blood fat). Response to current drugs Ideal scenario The new laboratory

Lluís Blanch: ‘The key is to go along with the professional who has an innovative idea’

Blanch said that “the key step is to go along with the professional who has an innovative idea” because researchers, doctors or nurses, said Blanch, do not know what steps should taketo negotiate with a company or what is the specific regulation of certain industrial sector. So Corporation Parc Taulí has a recovery and innovation …

Lluís Blanch: ‘The key is to go along with the professional who has an innovative idea’ Read More »

Scroll to Top